TREATMENT OF MYOFASCIAL PAIN SYNDROME WITH THE REDCORD SUSPENSION SYSTEM

Myofascial pain syndrome (MFPS) is a common cause of musculoskeletal pain, significantly reducing patients’ quality of life and limiting daily activities. Conventional treatment schemes, including medication and physical therapy, often provide only temporary relief, leading to a growing interest in alternative rehabilitation approaches. This article explores the use of the Redcord suspension system as an innovative method for rehabilitating patients with MFPS. The Neurac (Neuromuscular Activation) technique, utilized in the Redcord system, plays a key role in activating deep stabilizing muscles and restoring neuromuscular control. By partially unloading the body during exercises, this method reduces muscle imbalances, enhances joint mobility, and alleviates pain. Additionally, Redcord therapy promotes better coordination and motor control, making it particularly beneficial for patients with chronic musculoskeletal conditions. Clinical cases demonstrate the effectiveness of this approach in individuals suffering from chronic low back, neck, and shoulder pain. Patients report significant improvements in functional status, reduced muscle tension, and notable pain relief following a structured course of Redcord therapy. The Redcord suspension system represents a promising and comprehensive approach to treating MFPS by addressing neuromuscular dysfunctions at their root cause. However, further large-scale studies are required to optimize treatment protocols and confirm the long-term effectiveness of this technique across diverse patient populations. The aim of the study is to investigate the effectiveness of using the Redcord suspension system in the treatment of myofascial pain syndrome (MFPS) by activating deep muscles, restoring neuromuscular control and reducing pain. To evaluate the effect of this method on the functional status of patients with chronic musculoskeletal pain and to determine the possibility of its application in rehabilitation practice. A clinical study was conducted with the participation of patients diagnosed with myofascial pain syndrome (MFPS) who underwent a rehabilitation course using the Redcord suspension system. The study took place at the Department of Medical Rehabilitation at the University Hospital of KhNMU from September to December 2024. It included a comprehensive assessment of pain levels, functional status, and muscle activity before and after the course of therapy. Standardized measurement tools, including the visual analogue scale (VAS) for pain, functional movement tests, and electromyographic (EMG) analysis, were used to evaluate treatment outcomes. The study aimed to determine the effectiveness of Redcord therapy in enhancing neuromuscular function and alleviating pain symptoms. The use of the Redcord suspension system for the treatment of myofascial pain syndrome (MFPS) demonstrates significant efficacy in reducing pain symptoms, improving functional mobility, and restoring muscle stability. Most patients showed a significant reduction in pain intensity after the course of Redcord therapy, along with enhanced neuromuscular activation and movement efficiency. The average reduction in pain was 60-80% according to the visual analogue scale (VAS), with many patients also reporting improved quality of life and increased physical activity levels. Further studies are needed to explore long-term outcomes and optimize individualized treatment protocols. The Redcord suspension system is a promising method for treating myofascial pain syndrome. Its use helps activate deep muscles, restore neuromuscular control, and reduce pain by improving movement patterns and muscle coordination. Additionally, it offers a low-impact, adaptable approach suitable for various patient populations. However, further research is needed to determine optimal treatment protocols, evaluate long-term benefits, and confirm the effectiveness of this approach across different patient groups.